Lutz Liefeldt

Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy.

[Contraindications to living donor kidney transplantation].

FTY720 (fingolimod) in renal transplantation.

Soluble CD154 is a unique predictor of nonfatal and fatal atherothrombotic events in patients who have end-stage renal disease and are on hemodialysis.

Impact of kidney function on plasma troponin concentrations after coronary artery bypass grafting.

Outcomes of transplanting deceased-donor kidneys between elderly donors and recipients.

Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells.

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.

Enteric-coated mycophenolate sodium.

Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.

Inosine 5'-monophosphate dehydrogenase activity as a biomarker in the field of transplantation.

Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.

Outcomes after laparoscopic living donor nephrectomy: comparison of two laparoscopic surgeons with different levels of expertise.

Non-invasive imaging of living kidney donors: intraindividual comparison of multislice computed tomography angiography with magnetic resonance angiography.

Volume matters: CT-based renal cortex volume measurement in the evaluation of living kidney donors.

Human leukocyte antigen-incompatible kidney transplantation after "desensitization"--hope and reality.

Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients.

Advances in pharmacotherapy to treat kidney transplant rejection.

Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?

Influence of CT-based depth correction of renal scintigraphy in evaluation of living kidney donors on side selection and postoperative renal function: is it necessary to know the relative renal function?

Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantation.

Analysis of the Effects of Day-Time vs. Night-Time Surgery on Renal Transplant Patient Outcomes.

Predictors of graft survival at diagnosis of antibody-mediated renal allograft rejection: a retrospective single-center cohort study.

Native Nephrectomy before and after Renal Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Is a Retroaortic Vein a Risk Factor in Laparoscopic Living Donor Nephrectomy?

Robot-Assisted versus Laparoscopic Donor Nephrectomy: A Comparison of 250 Cases.

Inosine 5'-Monophosphate Dehydrogenase Activity for the Longitudinal Monitoring of Mycophenolic Acid Treatment in Kidney Allograft Recipients.

Should We Perform Old-for-Old Kidney Transplantation during the COVID-19 Pandemic? The Risk for Post-Operative Intensive Stay.

Extended Criteria Donors in Living Kidney Transplantation Including Donor Age, Smoking, Hypertension and BMI.

Low Seroprevalence of SARS-CoV-2 Antibodies during Systematic Antibody Screening and Serum Responses in Patients after COVID-19 in a German Transplant Center.

Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients.

What happens after graft loss? A large, long-term, single-center observation.

Asymptomatic secondary hyperparathyroidism can mimic sacroiliitis on computed tomography.

The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation.